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ABSTRACT
Providers of care for children undergoing stem cell transplantation (SCT) skillfully combine the roles of
scientist and clinician. As scientists, they apply scientific methods and disease theory in the creation and testing
of new therapies and in the careful observation and exploration of treatment outcomes. As clinicians, they are
capable of intuitively delivering care in a patient- and family-centered context of meaning and life values.
The specialty of SCT has inherent aspects that make treatment decision making complex and potentially
contentious. Having a strategy ready to implement in advance or at the time when treatment decisions need to
be made will facilitate and enhance the decision making process for both the health care team and family
members. Here we introduce the individualized care planning and coordination (ICPC) model as a practical
approach to facilitate ethical and effective decision making in pediatric SCT settings. The ICPC is a 3-step
model comprising (1) relationship—understanding the illness experience from the perspective of the patient
and family, sharing relevant information, and assessing ongoing needs; (2) negotiation—prognosticating,
establishing goals of care, and discussing treatment options; and (3) plan—generating a comprehensive plan of
care that includes life and medical plans. Based on a foundation of a care of competence, empathy, compassion,
communication, and quality, the ICPC model aims to diminish contentious family–staff interactions that can
lead to mistrust and help guide treatment decision making. The ICPC model enhances communication among
patients, families, and clinicians by revealing patient and family values and medical and quality-of-life priorities
before reaching or even during critical decision points in the transplantation process.
© 2007 American Society for Blood and Marrow Transplantation
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Health care providers of children undergoing
tem cell transplantation (SCT) have the difﬁcult task
f skillfully combining the roles of scientist and clini-
ian. As scientists, they apply scientiﬁc methods and
isease theory when creating and testing new thera-
ies and while observing and developing explanations
or treatment outcomes. As clinicians, they apply in-
uition-based knowledge to clinical situations to foster
atient- and family-centered care. These simultaneous
oles require the SCT clinician to be a humanist oractitioner who is skilled in treatment decision mak-
ng, competent in clinical care practices, and compas-
ionate and empathic in human interactions while
aintaining the ability to theoretically explain thera-
eutic and person-speciﬁc care outcomes.
Although cure rates in pediatric SCT have im-
roved, children undergoing this treatment modality
xperience a great deal of suffering, their quality of life
s signiﬁcantly threatened and families must often deal
ith uncertainty about outcomes and loss [1-3]. In
atients with childhood acute lymphocytic leukemia
r acute myeloid leukemia (AML) treated with ﬁrst
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J. N. Baker et al.246llogeneic transplantation, survival at 5 years ranges
rom 40% to 60% [4-6]. Survival rates for patients
ith acute leukemia of any sort who relapse after SCT
s poor, with leukemia-free survival after a second
llogeneic transplantation of only approximately 25%
7]. Morbidity during the immediate transplantation
eriod is signiﬁcant, with patients experiencing mu-
ositis, pain, veno-occlusive disease, and respiratory
omplications. These children are also more likely to
ie of treatment-related complications than are those
ho die secondary to a malignancy but without trans-
lantation as part of their treatment [8]. Furthermore,
atients, family members, and their clinicians experi-
nce signiﬁcant physical, emotional, and spiritual dis-
ress.
Clinicians for these seriously ill children will likely
ace difﬁcult and at times urgent treatment and care
ecisions that require or beneﬁt from the participation
f both the child and family [9,10]. These may be
ecisions about indications for procedures (eg, trans-
lantation), withholding of certain invasive therapies
eg, painful procedures), or withdrawing of life-pro-
onging measures (eg, mechanical ventilation). Other
cenarios may present ethical challenges, such as those
ncountered in the care of children with inescapable
uffering or in dealing with families who have unreal-
stic expectations and ask for interventions considered
edically inappropriate.
Treatment decision making in SCT can be com-
lex, potentially contentious, and sometimes required
romptly in response to changing clinical conditions
11-16]. Having a strategy ready to implement in
dvance will facilitate and enhance the decision mak-
ng process for the health care team, family members,
nd, when possible, the patient. A clinical decision
aking strategy also could help reduce contentious
amily–staff interactions and help guide decision mak-
ng by enhancing communication among the patient,
amily, and clinicians, revealing patient and family
alues and priorities before reaching or even during
ritical decision points in the transplantation process.
The individualized care planning and coordina-
ion (ICPC) model is a practical clinical strategy de-
igned to facilitate ethical and effective decision mak-
ng in the pediatric SCT setting. Because the ultimate
oal of SCT is to cure the child’s illness, care decisions
re likely to be both disease-directed and informed by
amily and patient preferences. A strategy designed to
acilitate treatment decision making in SCT needs to
e conceptually consonant with the cure-oriented fo-
us of transplantation while simultaneously attending
o the physical, emotional, and spiritual suffering that
hese pediatric patients and their families can experi-
nce [10]. The likelihood of signiﬁcant suffering, the
igh incidence of morbidity and mortality, and the
eed to make frequent difﬁcult decisions in an ethical
nd effective manner make the candidate pediatric fCT patient population eligible for the ICPC model.
n this article we use a contrived case presentation and
peciﬁc decision point questions to outline and inform
ach of the 7 components of the individualized care
lanning process for patients undergoing SCT.
ASE STUDY
Steve is an 11-year-old white male diagnosed with
cute myelogenous leukemia (AML) who underwent
ransplantation with a matched sibling donor approx-
mately 2 years ago. He has received news that his
eukemia has relapsed. He tolerated the previous
ransplantation with few complications. The patient
nd the family have requested a conference to discuss
reatment alternatives.
Questions:
. What signiﬁcance does understanding the illness
experience through the patient and family’s per-
spective play in recommendations that you will
make?
. What weight do the patient and family’s values
have in the decision making process?
. When communicating prognosis, what informa-
tion do you provide?
fter weighing the options of aggressive pain and
ymptom control only, palliative chemotherapy aimed
t life prolongation, and second allogeneic SCT, Steve
nd his family decide to enroll in an SCT clinical trial
or patients with relapsed AML after ﬁrst transplan-
ation.
Shortly after engraftment, Steve sustained multi-
rgan failure necessitating intubation and admission
o the intensive care unit. In the face of worsening
ultiorgan failure, the care team has a conference
ith the family.
Questions:
. How do you help integrate comfort care and the
child and family’s values into the care plan?
. Is there a point at which you would recommend
withholding or withdrawing treatment with cura-
tive intent?
. How would you proceed if the family requested
an intervention that you consider medically
inappropriate?
he family agrees to withhold further escalation of
reatment with curative intent. After this decision,
owever, Steve’s status stabilizes, and he is able to
ndergo extubation and transfer to the ﬂoor. He re-
ains anuric, necessitating continued daily dialysis,
nd his ascites continues to worsen, necessitating pe-
iodic paracentesis for comfort.
Steve begins to complain of increasing pain. Be-
ause of his grim prognosis and poor quality of life,
nother care conference is held. The family decides to
ocus on comfort care. They feel that life-sustaining
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Pediatric Stem Cell Transplantation Decision Making Model 247edical treatments (LSMTs) are “prolonging death
ather than prolonging life.” The family agrees to
lace a “do not resuscitate” order in Steve’s chart.
Question: Would you want to discuss the issue of
ithdrawing LSMTs, such as dialysis?
The next day, Steve’s symptoms increase, but the
edical team is able to keep him comfortable. Later in
he day, he dies, surrounded by family and friends.
Question: What is the physician’s role in the care
f the imminently dying patient and in this family’s
ubsequent experience?
HE ICPC MODEL
The foregoing case helps illustrate the need for a
ramework that can enhance the process of decision
aking, care planning, and care coordination [17].
ammes et al. [18] recently identiﬁed that advanced
Figure 1. Foundation of the ICPC model.
able 1. Key Terms in the ICPC Model
Term
ompetence Safe, appropriate, and effective care that re
in palliative and end-of-life care, and the
an ongoing process of ensuring clinical ex
ommunication A therapeutic tool involving verbal and non
central to a trusting clinician–patient rela
ompassion A deep feeling of sharing the suffering of an
mpathy Identifying and understanding the feelings,
uality Care that meets or exceeds all standards o
elationship A connection between people, facilitated be
experience from the perspective of the p
ongoing assessments of patient and famil
egotiation A mutual discussion and arrangement betw
consensus about care goals; often involve
onsensus Agreement about primary care goals in the
and is an essential step before developing
lan Generation of a comprehensive approach t
management alternatives, and a life plan, designare planning can be helpful in ensuring the best care,
roviding time and information to make decisions,
ommunicating desired care, and offering peace of
ind. The ICPC model involves a full spectrum of
are, from understanding the child and family’s
nique illness experiences (ie, their perceptions, ex-
ectations, hopes, wishes, and preferences), to sharing
f upsetting information (including conversations
bout potential care scenarios created in the context of
rognosis, realistic goals, and treatment options), and
nally establishing an effective care plan that reﬂects
areful consideration of all elements relevant to the
ecision making process and balances the use of treat-
ents with curative intent and supportive care inter-
entions designed to enhance the child and family’s
uality of life [19].
onceptual Foundation of Care in the
CPC Model
The conceptual bases of the ICPCmodel are com-
atible with pediatric palliative care practices directed
o attend suffering, promote healing, and improve
uality of life from the time of diagnosis of a life-
hreatening illness [10]. The ICPC has a concomitant
ocus on disease-directed care (medical plan) and re-
ationship and quality-of-life care planning (life plan).
t involves essential, interactive, and continually evolv-
ng concepts of treatment decision making: compe-
ence, communication, compassion, empathy, and
uality (Figure 1) [20-25]. Table 1 provides deﬁnitions
f these and other key terms. In SCT, where patient
orbidity and mortality rates are high, these founda-
ional concepts are a part of every patient, family, and
eam interaction.
In what follows, we use the case study of Steve and
is family to detail the 3 steps of the ICPC model
Figure 2).
Definition
rofessional excellence in SCT and a certain level of expertise
to function well as a member of an interdisciplinary care team;
e.
skills that can help reduce patient and parent suffering and is
ip.
coupled with a desire to help.
n, and motives of another.
ved practices
clinician and patient and family by understanding the illness
and family, sharing relevant information, and conducting
s.
e patient, family, and care team with the goal of reaching
f care scenarios.
iation process reached by the care team, patient, and family,
of care.
that includes a medical plan, designed to address diseaseflects p
ability
cellenc
verbal
tionsh
other
situatio
f appro
tween
atient
y need
een th
s use o
negot
a plan
o care
ed to achieve the child and family’s personal goals.
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J. N. Baker et al.248tep 1: Relationship
There are 3 components to this step: understand-
ng the illness experience from Steve and his family’s
erspective, sharing relevant information, and a com-
rehensive needs assessment of Steve and his family.
ddressing all 3 aspects of the relationship step will
llow for balanced insight into their care. This step
ill inform the recommendations and care scenarios
hat a clinician can provide Steve and his family as they
ork through this difﬁcult illness trajectory and con-
emplate decisions regarding proceeding with trans-
lantation or forgoing cure-oriented interventions.
igure 2. The 3-step individualized care planning and coordination
odel.
able 2. Examples of Exploratory, Empathic, and Validating Responses
Exploratory Responses Empat
What are you hoping for now?” Sit silently, note
with compassio
I want to listen to you tell me more about
that.”
“I can tell you we
this.”
What concerns you the most right now?” “I share your sad
Could you tell me what has been most
difficult for you so far?”
“I can see how u
What do you worry about happening next?” “We were all ho
You mentioned (name emotion), please tell
me more about that.”
“I find this to beata from Baile et al.Understanding the illness experience. Central to the
reatment decision making process is the clinician’s
bility to comprehend and appreciate the illness expe-
ience from the perspective of the patient and family
ithout judgment. Achieving this perspective is facil-
tated by learning from the child and family about
heir, wishes, perceptions, fears, preferences, beliefs,
nd values and how these contribute to their personal
ealities. The clinician’s ability to be comfortable with
ilence and create a safe, nonjudgmental atmosphere
onducive to open and honest communication helps
atients and families share their experiences.
Listening and empathic presence are powerful
ools in the transplantation clinician’s arsenal that
an affect patient and parent outcomes [26,27].
uestions and statements that can help elicit the
atient’s and family’s personal experiences are listed
n the left column of Table 2. The interdisciplinary
are team approach helps elicit these insights, which
ften are too difﬁcult for any single member of the
eam to elucidate.
Sharing relevant information. Patients and families
alue clear, concise, and accurate information to guide
heir decision making [28]. Using guided conversa-
ions to ensure that the patient and family’s educa-
ional needs are met by sharing speciﬁc information,
CT clinicians ensure their participation to the fullest
xtent possible.
There can be signiﬁcant barriers to consistently
ommunicating clearly and concisely with patients and
amilies. Findings from several studies indicate that
he bearer of bad news can elicit strong negative re-
ctions, such as anxiety and fear, in family members
26,27]. Anticipation of such reactions can contribute
o a clinician’s reluctance to deliver bad news, termed
he “MUM effect” [29]. This effect is particularly
trong when the recipient of the news is perceived to
lready be signiﬁcantly distressed [30].
A second barrier is the lack of any formal training
n communication among pediatric oncologists, in-
luding SCT clinicians. Only approximately 10% of
sponses Validating Responses
fering, respond “I believe I would have a similar feeling/
thought, too.”
xpecting to hear “Yes, what you said makes good sense
to me.”
“Your understanding of what I have said is
very good.”
g this is to you.” “Many other patients and families have had
similar experiences.”
r a better result.” “I respect what you said”
ery hard.” “It appears that you’ve thought things
through very well.”hic Re
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Pediatric Stem Cell Transplantation Decision Making Model 249ubspecialty-trained oncologists have received formal
ommunication training [31].
Careful planning facilitates sharing difﬁcult infor-
ation during face-to-face conversations [32]. Taking
n individualized yet systematic approach as is used in
he ICPC model can diminish clinician and family
pprehension and contribute to improved communi-
ation. The International Pediatric Oncology Society
SIOP) working group on psychosocial issues also sup-
orts the use of a protocol for communication while
ailoring information in patient- and family-speciﬁc
ays [33]. Examples of exploratory questions, em-
athic statements, and validating responses useful in
ifﬁcult conversations are given in Table 2.
Conducting an interdisciplinary needs assessment. An
ssessment of needs is patient- and family-centered,
omprehensive, and completed at regular intervals and
uring times of crises. These assessments are con-
ucted in a way that considers the child and family’s
ime, effort, and emotional burden and preferences.
he needs thereby identiﬁed are then linked to both
he plan of care and to indicators that measure patient
nd family outcomes [34].
One study of parents of dying children pointed to
heir desire for honest and complete information,
eady access to staff, care coordination, emotional
xpression and support by staff, preservation of the
ntegrity of the parent–child relationship, and faith
35]. Patient needs will vary by age of the child and
able 3. Domains of Interdisciplinary Needs Assessment with Examples
Assessment Domain
tructure and process of care ● Specialty-level trained symptom
● The setting of care should mee
● The care plan is based on a co
hysical aspects of care ● Symptoms and side effects are
● Symptoms and side effects are
centered.
sychological/psychiatric
aspects of care
● Psychological/psychiatric needs
● Grief and bereavement progra
ocial aspects of care ● Comprehensive interdisciplina
piritual, religious, existential
aspects of care
● Spiritual and existential dimen
evidence.
● Spiritual and existential dimen
and family as they pertain to t
ultural aspects of care ● Needs are assessed in a cultura
● Specific patient and family cult
are of the imminently dying ● During this stage of the illness
● Signs and symptoms of impend
needed.
thical and legal aspects of
care
● Healthcare professionals assess
each patient and family.
● Need for ethics consultation sh
discordant steps in the process
ducational aspects of care ● Comprehensive interdisciplina
patients and families.
● Specific patient and family info
elational aspects of care ● As a part of the generation of● Relationships are assessed and augmeotentially by their clinical situation [36]. In a study of
ediatric cancer patients participating in a phase I
linical trial, adolescents reported that their relation-
hips with others were the primary factors inﬂuencing
heir treatment decision making, and, furthermore,
hat their motivation to participate in the trial was
ooted in altruism and a desire to beneﬁt others [37].
Without an ongoing needs assessment, care out-
omes may be compromised and the ICPC process
eft incomplete. This component of the process incor-
orates ongoing assessments of the patient, family
embers, clinicians, and care system. Table 3 lists
xamples of each domain of a comprehensive interdis-
iplinary needs assessment [38].
tep 2: Negotiation
Because of the trust that has been created and the
elationship that has been established between the
are team and Steve and his family, speciﬁc care sce-
arios can be provided and the process of negotiation
an begin. This step combines prognosticating and
iscussing goals of care and speciﬁc treatment options
or Steve and his family to consider, in an attempt to
chieve consensus before moving on to create a com-
rehensive care plan.
These discussions are intrinsically difﬁcult because
hey include conversations about emotionally charged
vents that are future possibilities. Contrasting possi-
Examples
agement experts available.
references, needs, and circumstances of the patient and family.
ensive interdisciplinary assessment.
ed and managed in a timely, safe, and effective manner.
ed and managed in a manner that is patient and family-
sessed and managed in a timely, safe, and effective manner.
ailable to assess and manage patient, family, and staff grief.
ssment identifies the social needs of patients and families.
re assessed and responded to based on the best available
re approached in a manner that is acceptable to the patient
ent’s illness.
sitive manner.
eds are assessed.
ory, the comprehensive needs assessment continues.
ath are assessed, recognized, communicated, and treated as
ttempt to incorporate the values, goals, and preferences of
e assessed based on the comprehensive needs assessment and
ure as primary goal in end-stage cancer).
ssment identifies the informational and educational needs of
n is provided in a timely manner.
lan, the relational needs of the patient and family are assessed.man
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J. N. Baker et al.250le care scenarios is a pragmatic and particularly use-
ul strategy for guiding these difﬁcult conversations by
resenting available treatment options within the
ramework set up by the prognosis and an overreach-
ng goal of care. This step will encourage informed
ecision making for Steve and his family as they work
hrough the difﬁcult illness trajectory and contemplate
ecisions at each of the key time points in the case.
Establishing prognoses and communicating them
ffectively. Developing a prediction of the probable
ourse and likely outcome of an illness and then con-
eying this to both the patient and the family can help
hem cope with the inherent uncertainty of treatment.
his may help them develop an accurate understand-
ng of the clinical realities while also maintaining a
ense of hope. Technology in the pediatric SCT set-
ing continues to advance and evolve, and new ap-
roaches are constantly under investigation, making
rognostication quite difﬁcult for health care provid-
rs. Yet it is precisely this kind of information that
atients and families ﬁnd helpful in their decision
aking [39,40]. A thoughtful discussion of prognosis
llows clinicians, patients and families to begin ﬁnding
ommon ground related to patient and family goals. In
ne study of prognosis in pediatric oncology patients,
hildren whose parents understood the seriousness of
he clinical situation earlier in the process had better
ymptom control at end of life and greater access to
uality-of-life services, such as hospice [41].
Although research on prognosis in children with
ancer is limited, the existing data are helpful in cer-
ain situations. For example, the response rate for
atients enrolled in phase II clinical trials is  20%,
nd their progression-free survival is 12.9% at 2 years
nd 9.2% at 5 years [42]. Furthermore, the response
ate in patients with advanced disease who receive
hase I experimental drugs is  7.9% [43].
Estimating prognosis accurately and then commu-
icating this information empathically and compas-
ionately to the patient and family is an advanced skill
hat requires sincerity and clinical sophistication.
hese discussions include the possibility of cure, of
mprovement or death, and the likelihood that the
atient’s life may be shortened or prolonged with the
se of certain care interventions. In addition, infor-
ation about the likelihood of the interventions add-
ng to patient suffering, comfort, or improved quality
f life is a part of prognosis discussions. The clinician’s
ole also includes assessing the patient and family’s
nderstanding of the information about prognosis,
heir hopes, and how they use the information con-
eyed to make decisions about care.
Discussing goals of care. A thoughtful discussion of
rognostic information precedes establishing goals of
are [44]. Figure 3 shows a useful model for guiding
hese often-difﬁcult conversations. The primary goal
f cure may be agreed on when the evidence suggests fhis as a realistic possibility or when a patient or
amily’s hopes for cure are high (ie, phase III clinical
rial or its equivalent). Here most, if not all, patients,
amilies, and clinicians work under the assumption
hat care includes the use of artiﬁcial LSMTs and
ther invasive procedures, because these interventions
re considered necessary for cure. When cure is the
rimary goal, the psychological stance is “to conquer
isease;” this stance will direct treatment decision
aking that will include invasive care interventions
hat can be associated with higher morbidity.
At differing points during treatment, and for di-
erse reasons, patients and their family members may
egin to experience a quiet, gradual realization that
he once-primary goal of cure is no longer a realistic
ossibility. Instead, the goal may become life pro-
ongation, and conversations at this stage may be
uided toward questions of how this goal may be
chieved, the quality of the life being prolonged,
nd the patient and family’s goals during the time
emaining. The psychological stance at this stage is
to ﬁght.” Patients and families are likely to consider
reatments with mild to moderate toxicity that offer
he possibility of tumor response, including temporary
rrest of growth, while also focusing on symptom relief.
Guided conversations about the beneﬁts and bur-
ens of each viable intervention includes the possible
ffectiveness of each as a life-prolonging measure,
long with the potential positive or adverse affect on
he patient and family’s suffering and quality of life.
he outcome of these conversations is whether and
hich interventions can or should be withheld or
nitiated. These conversations tend to include discus-
ions about resuscitation preferences, as well as
hether or not to use LSMTs, with a careful consid-
ration of the impact of each option on patient and
amily comfort and their quality-of-life goals.
Understandably, clinicians have reported a desire
o forsake such conversations for fear that patients and
Figure 3. Goals of care.amilies will react with feelings of hopelessness or
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Pediatric Stem Cell Transplantation Decision Making Model 251bandonment [45,46]. These conversations about life
rolongation are most effective when they convey
espect for the hope for cure that most families will
ontinue to experience regardless of the child’s present
tatus [45-47].
Farther along in the disease process, signiﬁcant
uffering combined with an increasing awareness of
he likelihood of death may steer the patient, family,
nd clinician to consider comfort as the primary goal
n the child’s care. Patients and families gradually and
nevenly begin to perceive a need to prevent further
nterventions that contribute to suffering and poor qual-
ty of life. Families will likely need the clinician’s support
nd ongoing reassurance that they do have an accurate
rasp of their child’s clinical situation, with cure or life
rolongation no longer the primary goal of care. The
sychological stance as comfort becomes the primary
oal is “to protect from suffering.” Guided conversations
t this point in the illness trajectory may include more
xploration of personal values (ie, faith, prayer) or com-
lementary and alternative medicine [41].
The purposes of conversations regarding primary
are goals are to facilitate communication about treat-
ent decision making, to establish a common lan-
uage around care issues and care priorities, and to
olidify a trusting relationship between the family and
linicians. The goal of providing comfort is a constant
are priority, but when cure is the primary goal, the
otential beneﬁt of an intervention such as SCT will
verride the risk of potential adverse side effects. The
verlapping care priorities that constitute the clinical
ontext of the SCT trajectory is depicted in the over-
apping circles in Figure 3. Thoughtful consideration
f an overreaching goal does not imply a simplistic
iew of a complex process, but rather aims to suggest
framework within which secondary goals may be
eviewed and the intent of medical and supportive care
nterventions can be negotiated. The overlapping cir-
les also represent the ongoing effort in SCT to reas-
ess goals at regular intervals and during crises.
Discussing treatment options. One standard in med-
cal ethics is shared treatment decision making involv-
ng the patient, family or designated surrogate, and
linicians [48]. The assumption is that these conver-
ations will yield a medically and culturally appropri-
te, effective, and ethical plan of care that is in the best
nterest of the child and family. Participants in the
reatment decision making process will consider the
urdens and beneﬁts of proposed medical interven-
ions in light of existing clinical realities (prognosis)
nd of the patient and family’s values, beliefs, and
references.
Contrasting potential clinical care scenarios linked
o each primary and secondary goal is a pragmatic
trategy during these difﬁcult conversations. When
are options such as not escalating, withholding, or
ithdrawing treatment with curative intent are being hiscussed, supportive care alternatives need to be de-
ineated. Families are less likely to fear discontinua-
ion of certain therapies if they perceive that support-
ve care is readily available to help them achieve their
ersonal goals [49]. Seasoned clinicians prepare them-
elves for these discussions because they know that
hese topics can challenge exhausted coping mecha-
isms relied on by patients and families. The clini-
ian’s sensitivity, availability, and ability to respect the
eactions from patients and family members to these
iscussions will help achieve a consensus when con-
idering care options.
tep 3: Plan
Once the clinicians, Steve, and his family have
rrived at a consensus approach to care through ne-
otiation and based on their interpersonal relation-
hips, a comprehensive care plan can be generated.
he ICPC process guides the development of a care
lan that takes into account their needs, values, and
erceptions, as well as the medical care that would
eneﬁt Steve’s illness.
Creating a comprehensive care plan: Integrating a
edical plan and a life plan. A total or comprehensive
are plan integrates the medical plan, designed to
ddress disease management alternatives, and the life
lan, designed to address personal goals and values.
he medical plan reﬂects decisions about disease treat-
ent, such as whether or not to use LSMTs, administer
ransfusions, collect blood samples for anlaysis, or initi-
te intrusive procedures. The life plan addresses rela-
ional needs and personal goals, such as a plan to attend
n important social event or embark on a family trip that
ay entail some health risks. Commonly, the life plan
lso addresses sibling and family needs.
Easy access to the comprehensive care plan by
embers of the interdisciplinary care team facilitates
mplementation of the plan. Effective documentation
f the plan using a decision making tool for pediatric
alliative care patients and their families has been
reviously demonstrated [50]. A guide for document-
ng the ICPC process is included as an Appendix to
his article.
The weight given to each component plan of the
omprehensive care plan will shift depending on de-
ision point [51]. The medical plan, with its emphasis
n disease, likely would be given more weight during
he curative phase of therapy, whereas the life plan,
ith its emphasis on personal values, would prevail in
ases of incurable illness. The concurrent use of both
lans is a strategy for generating a comprehensive care
lan. Maltoni et al. [52] have developed evidence-
ased clinical recommendations addressing how these
eeds can be extracted in conversation with adults
ith advanced cancer, but no such recommendations
ave been made for children.
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J. N. Baker et al.252ndividualized Care Coordination
The individualized care coordination component
f the ICPC model is a strategy for implementing the
omprehensive care plan. As a medical home for chil-
ren living with life-threatening illnesses, SCT pro-
rams provide family-centered comprehensive care
53]. Fragmentation in the care of patients undergoing
CT can result from barriers in communication and
ollaboration among the interdisciplinary team mem-
ers, as well as between the tertiary care center and
utside care settings. The ICPC model may be used as
quality improvement strategy in this setting to ad-
ress such priority areas as end-of-life care, pain man-
gement, and care coordination [25].
Individualized care coordination can limit frag-
entation by orchestrating the delivery of services
hile advocating for the goal-directed therapies and
upportive care interventions established in the com-
rehensive care plan. The plan is designed for imple-
entation across the multiple settings in which the
hild and family receive care. Having a designated team
ember assigned to ensure coordinated implementation
f the care plan across settings is a particularly helpful
pproach. Responsibilities for this designated team
ember could include facilitating the child and family’s
articipation in the decision making process, participat-
ng in conﬂict resolution, and advocating for the child
nd family according to their preferences as documented
n the medical and life plans [54].
ONCLUSION
Formally incorporating individualized care plan-
ing into SCT program policies and procedures will
acilitate treatment decision making in the care of
atients with progressive disease after transplantation,
nd also provide care for patients who are likely to
uffer from treatment-related morbidity and mortality
55]. Implementing and evaluating the ICPC model
ill help ensure patient- and family-centered care
efore, during, and after the difﬁcult decision making
egarding care and treatment inherent to SCT.
Affected by the impact of disease theory in mod-
rn medicine, the success of bone marrow transplan-
ation as a science may be measured in terms of in-
reased cure rate or disease-free survival, limited
oxicity, and decreased complications. We do not have
he equal ability to measure the success of SCT in
erms of its less tangible, more subjective aspects of
are, such as the processes involved in attending to
uffering, promoting healing, supporting the dying
hild and family, and effective decision making [56].
he ICPC model is likely to have a signiﬁcant impact
n these important care processes as well. Quality
ndicators that demonstrate the beneﬁt of the ICPC
odel must be identiﬁed and evaluated.CKNOWLEDGMENTS
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PPENDIX: GUIDELINES FOR DOCUMENTING THE
CPC PROCESS
tep 1: Relationship
nderstand the child and family’s unique illness experience
Listen to the illness experience from the child’s
and family’s perspective.
Encourage the child and family to describe their
perceptions of illness, sources of hope and suffering,
and possible death and to express their end-of-life
care preferences and expectations from health care
professionals.
Identify the child and family’s fears and outline
their coping mechanisms.
Note the child and family’s belief and value
systems.
Use caring presence and empathy as tools to help
facilitate the process.
hare relevant information
Recognize the child and family’s need for infor-
mation to guide the decision making process.
Identify the main decision maker(s) within the
family unit.
Evaluate the child’s role in the decision making
process.
Note speciﬁc information shared with the child
and family.
eeds assessment
Conduct a comprehensive assessment of the child
and family’s needs.
Describe the needs according to the domains of
the illness experience, including the structure and
process of care, physical, emotional, social, spiri-
tual, cultural, ethical and legal, educational and
relational aspects of care, as well as the needs of
imminently dying children and their families.
Use an interdisciplinary team approach.
tep 2: Negotiation
rognoses
Establish speciﬁc prognoses as outlined in the
literature and/or based on clinical experience.
Communicate the prognoses effectively to the
child and/or family.
Describe and document estimates of prognosis for
survival and/or death, comfort and/or suffering, and
life expectancy and/or clinical improvement.
Note the speciﬁcs of who the information was
given to: child, parent, and/or surrogate.
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the prognoses.
Note how information on prognosis is used in the
decision making process.
oals
Consider an overreaching goal of care suitable to
the child’s prognosis and the child’s and family’s
personal illness experience.
Describe the child’s and family’s perceptions of
an overreaching goal of care in the context of
their personal realities and value system.
Outline secondary medical goals.
Outline personal and life goals.
reatment options
Create a case scenario most consistent with the
child’s and family’s personal realities and value
system to illustrate the treatment options.
Outline consensus about treatment options that
may support the achievement of goals.
tep 3: Plan
ocument a comprehensive care plan; document the plan
or each domain
Disease management, for example, chemother-
apy, radiotherapy, surgery, antibiotics, supportive
care, artiﬁcial LSMTs, hospitalization, and emer-
gency room visits.
Physical aspects of care, for example, pain con-
trol, symptom control, rehabilitation.
Psychological aspects of care, for example, emo-
tional, grief, bereavement, anxiety, depression,
maladaptive behavior.
Spiritual aspects of care, for example, hope,
meaning, faith, religious practices.
Social aspects of care, for example, sibling and
parent support, self care, ﬁnancial support.
Cultural aspects of care: a speciﬁc plan based on
cultural needs.
Care of imminently dying, for example, symp-
toms, coping, anticipatory guidelines, communi-
cation, grief, funeral arrangements.
Ethical and legal aspects of care, including ethics
consult, risk management, staff education, ines-
capable suffering, and so on. Document whether
the plan includes withholding or withdrawing
speciﬁc treatment with curative intent.
Educational aspects of care, such as death and
dying, anticipatory guidelines, home health, hos-
pice, and other.
Relational aspects of care, such as the opportuni-
ties for expression of love, gratitude, forgiveness,
and farewell.
Structure of care, such as utilization of resources,
care coordination plans, and discharge planning.EFERENCES
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